NeuShen Therapeutics is a biotechnology startup founded in 2021, with a focus on pioneering the future of neurological and psychiatric treatment. Their slogan, "Pioneering the future of neurological and psychiatric treatment," aligns with their mission to revolutionize the treatment of neurological and psychiatric disorders. The company recently secured a $20.00M Seed Round investment on 29 September 2022, with notable investors including Lapam Capital and BioVenture. NeuShen Therapeutics' innovative approach to biotechnology positions them as a promising player in the industry.
No recent news or press coverage available for NeuShen Therapeutics.